The "Vulnerable" Stent. Why So Dreadful?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 25, 2008, Pages 2403-2406

  Alfonso, Fernando ^a  

^a Cardiovascular Institute   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOPLASTY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EDITORIAL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; IMPLANTATION; INFLAMMATORY DISEASE; MORTALITY; PRIORITY JOURNAL;

CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 44949121635     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.03.029     Document Type: Editorial

References (17)

1. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108 (2003) 1664-1672
2. Stone G.W., Moses J.W., Ellis S.G., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
3. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
4. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
5. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al., BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of the drug-eluting verus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
6. Lagerqvist B., James S.K., Stenestrand U., Lindbäck J., Nilsson T., Wallentin L., and SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
7. Tu J.V., Bowen J., Chiu M., et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357 (2007) 1393-1402
8. Marroquin O.C., Selzer F., Mulukutla S.R., et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 358 (2008) 342-352
9. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and placitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
10. Alfonso F., Suárez A., Angiolillo D.J., et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart 90 (2004) 1455-1459
11. Alfonso F., Suárez A., Pérez-Vizcayno M.J., et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 50 (2007) 2095-2097
12. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
13. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
14. de la Torre-Hernández J.M., Alfonso F., Hernández F., et al. Drug-eluting stent thrombosis. Results from the multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivo). J Am Coll Cardiol 51 (2008) 986-990
15. Chechi T., Vecchio S., Vittori G., et al. ST-segment elevation myocardial infarction due to early and late stent thrombosis: a new group of high-risk patients. J Am Coll Cardiol 51 (2008) 2396-2402
16. Alfonso F., Rodriguez P., Phillips P., et al. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions. J Am Coll Cardiol 29 (1997) 725-733
17. Alfonso F., and Angiolillo D.J. Platelet function assessment to predict outcomes after coronary interventions: hype or hope?. J Am Coll Cardiol 48 (2006) 1751-1754